Document:

EXHIBIT
10.5

 

PLACEMENT
AGENT WARRANT

 

INTELLINETICS,
INC.

Warrant
No. PA3-[00__]

WARRANT
TO PURCHASE COMMON STOCK

 

VOID
AFTER 5:00 P.M., EASTERN TIME,

ON THE EXPIRATION DATE

 

THIS
WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED, DONATED OR OTHERWISE
TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION FROM SUCH REGISTRATION.

 

FOR
VALUE RECEIVED, Intellinetics, Inc., a Nevada corporation (the “Company”), hereby agrees to sell
upon the terms and on the conditions hereinafter set forth, at any time commencing on the date hereof but no later than 5:00 p.m.,
Eastern Time, on [November 30, 2022] (the “Expiration Date”), to ________________, or its registered
assigns (the “Holder”), under the terms as hereinafter set forth, [___________ (_______)] fully paid
and non-assessable shares of the Company’s Common Stock, par value $0.001 per share (the “Common Stock”),
at a purchase price per share of Twenty-Five cents ($0.25) (the “Warrant Price”), pursuant to the terms
and conditions set forth in this warrant (this “Warrant”). The number of shares of Common Stock issued
upon exercise of this Warrant (“Warrant Shares”) and the Warrant Price are subject to adjustment in
certain events as hereinafter set forth.

 

1.
Exercise of Warrant.

 

(a)
The Holder may exercise this Warrant at any time after issuance according to the terms and conditions set forth herein by delivering
to the Company, at the address of the Company set forth in Section 10 prior to 5:00 p.m., Eastern Time, at any time prior to the
Expiration Date (such date of exercise, the “Exercise Date”) (i) this Warrant, (ii) the Subscription
Form attached hereto as Exhibit A (the “Subscription Form”) (having then been duly executed by
the Holder), (iii) unless the Warrant is being exercised pursuant to a Cashless Exercise (as defined below), cash, a certified
check or a bank draft in payment of the purchase price, in lawful money of the United States of America, for the number of Warrant
Shares specified in the Subscription Form.

 

(b)
This Warrant may be exercised in whole or in part so long as any exercise in part hereof would not involve the issuance of fractional
Warrant Shares. If exercised in part, the Company shall deliver to the Holder a new Warrant, identical in form to this Warrant,
in the name of the Holder, evidencing the right to purchase the number of Warrant Shares as to which this Warrant has not been
exercised, which new Warrant shall be signed by the President or Chief Executive Officer of the Company. The term Warrant as used
herein shall include any subsequent Warrant issued as provided herein.

 

(c)
Notwithstanding any provisions herein to the contrary, in lieu of exercising this Warrant in the manner set forth in Section 1(a),
the Holder may elect to exercise this Warrant, or a portion hereof, and to pay for the Warrant Shares by way of cashless exercise
(a “Cashless Exercise”). If the Holder wishes to effect a cashless exercise, the Holder shall deliver
the Exercise Notice duly executed by such Holder or by such Holder’s duly authorized attorney, at the principal office of
the Company, or at such other office or agency as the Company may designate in writing prior to the date of such exercise, in
which event the Company shall issue to the registered Holder the number of Warrant Shares computed according to the following
equation:

 

 

    	 	 	 

     

    

 

;
where

 

X
= the number of Warrant Shares to be issued to the registered Holder.

 

Y
= the Warrant Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the
Warrant Shares being exercised.

 

A
= the Fair Market Value (defined below) of one share of Common Stock on the Exercise Date.

 

B
= the Exercise Price (as adjusted pursuant to the provisions of this Warrant).

 

For
purposes of this Section 1(c), the “Fair Market Value” of one share of Common Stock on the Exercise Date shall have
one of the following meanings:

 

(1)
if the Common Stock is traded on a national securities exchange, the Fair Market Value shall be deemed to be the Closing Price
on the trading day preceding the Exercise Date. For the purposes of this Warrant, “Closing Price” means the closing
sale price of one share of Common Stock, as reported by Bloomberg; or

 

(2)
if the Common Stock is traded over-the-counter, the Fair Market Value shall be deemed to be the Closing Price on the trading day
immediately preceding the Exercise Date; or

 

(3)
if neither (1) nor (2) is applicable, the Fair Market Value shall be at the commercially reasonable price per share which the
Company could obtain on the Exercise Date from a willing buyer (not a current employee or director) for shares of Common Stock
sold by the Company, from authorized but unissued shares, as determined in good faith by the Company’s Board of Directors.

 

For
illustration purposes only, if this Warrant entitles the Holder the right to purchase 100,000 Warrant Shares and the Holder were
to exercise this Warrant for 50,000 Warrant Shares at a time when the Exercise Price per share was $1.00 and the Fair Market Value
of each share of Common Stock was $2.00 on the Exercise Date, as applicable, the cashless exercise calculation would be as follows:

 

X
= 50,000 ($2.00-$1.00)

2.00

 

X
= 25,000

 

Therefore,
the number of Warrant Shares to be issued to the Holder after giving effect to the cashless exercise would be 25,000 Warrant Shares
and the Company would issue the Holder a new Warrant to purchase 50,000 Warrant Shares, reflecting the portion of this Warrant
not exercised by the Holder. For purposes of Rule 144 promulgated under the Securities Act of 1933, as amended (the “Securities
Act”), it is intended, understood and acknowledged that the Warrant Shares issued in the cashless exercise transaction
described pursuant to Section 1(c) shall be deemed to have been acquired by the Holder, and the holding period for the shares
of Warrant Shares shall be deemed to have commenced, on the date of the Holder’s acquisition of the Warrant.

 

(d)
No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon the exercise of this Warrant.
The Company shall pay cash in lieu of such fractional Warrant Shares. The price of a fractional Warrant Share shall equal the
product of (i) the closing price of the Common Stock on the exchange or market on which the Common Stock is then traded (if the
Common Stock is not then publicly traded, then upon the fair market value per share of the Common Stock (as determined by the
Company’s Board of Directors)), and (ii) the applicable fraction.

 

    	 	 2	 

     

    

 

(e)
In the event of any exercise of the rights represented by this Warrant, a certificate or certificates for Warrant Shares so purchased,
registered in the name of the Holder on the stock transfer books of the Company, shall be delivered to the Holder within a reasonable
time after such rights shall have been so exercised. The person or entity in whose name any certificate for Warrant Shares is
issued upon exercise of the rights represented by this Warrant shall for all purposes be deemed to have become the holder of record
of such Warrant Shares immediately prior to the close of business on the date on which the Warrant was surrendered and payment
of the Warrant Price and any applicable taxes was made, irrespective of the date of delivery of such certificate, except that,
if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall
be deemed to have become the holder of such shares at the opening of business on the next succeeding date on which the Company’s
stock transfer books are open. Except as provided in Section 4 hereof, the Company shall pay any and all documentary stamp or
similar issue payable in respect of the issue or delivery of Warrant Shares on exercise of this Warrant.

 

(f)
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

 

2.
Disposition of Warrant Shares and Warrant.

 

(a)
The Holder hereby acknowledges that: (i) this Warrant and any Warrant Shares purchased pursuant hereto are not being registered
(A) under the Securities Act of 1933 (the “Act”) on the ground that the issuance of this Warrant is
exempt from registration under Section 4(a)(2) of the Act as not involving any public offering, or (B) under any applicable state
securities law because the issuance of this Warrant does not involve any public offering; and (ii) that the Company’s reliance
on the registration exemption under Section 4(a)(2) of the Act and under applicable state securities laws is predicated in part
on the representations hereby made to the Company by the Holder. The Holder represents and warrants that he, she or it is acquiring
this Warrant and will acquire Warrant Shares for investment for his, her or its own account, with no present intention of dividing
his, her or its participation with others or reselling or otherwise distributing this Warrant or Warrant Shares.

 

(b)
The Holder hereby agrees that he, she or it will not sell, transfer, pledge or otherwise dispose of (collectively, “Transfer”)
all or any part of this Warrant and/or Warrant Shares unless and until he, she or it shall have first have given notice to the
Company describing such Transfer and furnished to the Company (i) a statement from the transferee, whereby the transferee represents
and warrants that he, she, or it is acquiring this Warrant and will acquire Warrant Shares, as applicable, for investment for
his, her or its own account, with no present intention of dividing his, her or its participation with others or reselling or otherwise
distributing this Warrant or Warrant Shares, as applicable, and either (ii) an opinion, reasonably satisfactory to counsel for
the Company, of counsel (competent in securities matters, selected by the Holder and reasonably satisfactory to the Company) to
the effect that the proposed Transfer may be made without registration under the Act and without registration or qualification
under any state law, or (iii) an interpretative letter from the U.S. Securities and Exchange Commission to the effect that no
enforcement action will be recommended if the proposed sale or transfer is made without registration under the Act.

 

(c)
If, at the time of issuance of Warrant Shares, no registration statement is in effect with respect to such shares under applicable
provisions of the Act, the Company may, at its election, require that (i) the Holder provide written reconfirmation of the Holder’s
investment intent to the Company, and (ii) any stock certificate evidencing Warrant Shares shall bear legends reading substantially
as follows:

 

“THE
SALE, TRANSFER, PLEDGE OR OTHER DISPOSITION OF THE SHARES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO CERTAIN RESTRICTIONS SET
FORTH IN THE WARRANT PURSUANT TO WHICH THESE SHARES WERE PURCHASED FROM THE COMPANY. COPIES OF SUCH RESTRICTIONS ARE ON FILE AT
THE PRINCIPAL OFFICES OF THE COMPANY. NO TRANSFER OF SUCH SHARES OR OF THIS CERTIFICATE (OR OF ANY SHARES OR OTHER SECURITIES
(OR CERTIFICATES THEREFOR) ISSUED IN EXCHANGE FOR OR IN RESPECT OF SUCH SHARES) SHALL BE EFFECTIVE UNLESS AND UNTIL THE TERMS
AND CONDITIONS SET FORTH IN THE WARRANT HAVE BEEN COMPLIED WITH.”

 

    	 	 3	 

     

    

 

“THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND MAY NOT BE SOLD, TRANSFERRED,
PLEDGED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (THE “ACT”)
OR AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THIS CERTIFICATE THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT.”

 

In
addition, so long as the foregoing legend may remain on any stock certificate evidencing Warrant Shares, the Company may maintain
appropriate “stop transfer” orders with respect to such certificates and the shares represented thereby on its books
and records and with those to whom it may delegate registrar and transfer functions.

 

3. Reservation
of Shares. The Company hereby agrees that at all times there shall be reserved for issuance upon the exercise of this
Warrant such number of shares of the Common Stock as shall be required for issuance upon exercise of this Warrant. The Company
further agrees that all Warrant Shares will be duly authorized and will, upon issuance and payment of the exercise price therefor,
be validly issued, fully paid and non-assessable, free from all taxes, liens, charges and encumbrances with respect to the issuance
thereof, other than taxes, if any, in respect of any transfer occurring contemporaneously with such issuance and other than transfer
restrictions imposed by federal and state securities laws.

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant. Without
limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise
of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under
this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.

 

4. Exchange,
Transfer or Assignment of Warrant. Subject to Section 2, this Warrant is exchangeable, without expense, at the option
of the Holder, upon presentation and surrender hereof to the Company or at the office of its stock transfer agent, if any, for
other Warrants of the Company (“Warrants”) of different denominations, entitling the Holder or Holders
thereof to purchase in the aggregate the same number of Warrant Shares purchasable hereunder. Subject to Section 2, upon surrender
of this Warrant to the Company or at the office of its stock transfer agent, if any, together with (a) the Assignment Form attached
hereto as Exhibit B (the “Assignment Form”) duly executed, (b) an opinion of counsel to the Holder
(if required by the Company), in a form reasonably acceptable to the Company, that registration under the Securities Act is not
required, and (c) funds sufficient to pay any transfer tax, the Company shall, without charge, execute and deliver a new Warrant
in the name of the assignee named in the Assignment Form and this Warrant shall promptly be canceled. Subject to Section 2, this
Warrant may be divided or combined with other Warrants that carry the same rights upon presentation hereof at the office of the
Company or at the office of its stock transfer agent, if any, together with a written notice specifying the names and denominations
in which new Warrants are to be issued and signed by the Holder hereof.

 

    	 	 4	 

     

    

 

5. Capital
Adjustments. This Warrant is subject to the following further provisions:

 

(a)
Recapitalization, Reclassification and Succession. If any recapitalization of the Company or reclassification of its Common
Stock or any merger or consolidation of the Company into or with a corporation or other business entity, or the sale or transfer
of all or substantially all of the Company’s assets or of any successor corporation’s assets to any other corporation
or business entity (any such corporation or other business entity being included within the meaning of the term “successor
corporation”) shall be effected, at any time while this Warrant remains outstanding and unexpired, then, as a condition
of such recapitalization, reclassification, merger, consolidation, sale or transfer, lawful and adequate provision shall be made
whereby the Holder of this Warrant thereafter shall have the right to receive upon the exercise hereof as provided in Section
1 and in lieu of the Warrant Shares immediately theretofore issuable upon the exercise of this Warrant, such shares of capital
stock, securities or other property as may be issued or payable with respect to or in exchange for the number of outstanding shares
of Common Stock equal to the number of Warrant Shares immediately theretofore issuable upon the exercise of this Warrant had such
recapitalization, reclassification, merger, consolidation, sale or transfer not taken place, and in each such case, the terms
of this Warrant shall be applicable to the shares of stock or other securities or property receivable upon the exercise of this
Warrant after such consummation.

 

(b)
Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall
subdivide or combine its Common Stock, the number of Warrant Shares purchasable upon exercise of this Warrant shall be proportionately
adjusted.

 

(c)
Stock Dividends and Distributions. If the Company at any time while this Warrant is outstanding and unexpired shall issue
or pay the holders of its Common Stock, or take a record of the holders of its Common Stock for the purpose of entitling them
to receive, a dividend payable in, or other distribution of, Common Stock, then the number of Warrant Shares purchasable upon
exercise of this Warrant shall be adjusted to the number of shares of Common Stock that Holder would have owned immediately following
such action had this Warrant been exercised immediately prior thereto.

 

(d)
Price Adjustments. Whenever the number of Warrant Shares purchasable upon exercise of this Warrant is adjusted pursuant
to Sections 5(b), 5(c) or 5(d), the then applicable Warrant Price shall be proportionately adjusted.

 

(e)
Certain Shares Excluded. The number of shares of Common Stock outstanding at any given time for purposes of the adjustments
set forth in this Section 5 shall exclude any shares then directly or indirectly held in the treasury of the Company.

 

(f)
Deferral and Cumulation of De Minimis Adjustments. The Company shall not be required to make any adjustment pursuant to
this Section 5 if the amount of such adjustment would be less than one percent (1%) of the Warrant Price in effect immediately
before the event that would otherwise have given rise to such adjustment. In such case, however, any adjustment that would otherwise
have been required to be made shall be made at the time of and together with the next subsequent adjustment which, together with
any adjustment or adjustments so carried forward, shall amount to not less than one percent (1%) of the Warrant Price in effect
immediately before the event giving rise to such next subsequent adjustment. All calculations under this Section 5 shall be made
to the nearest cent or to the nearest one-hundredth of a share, as the case may be, but in no event shall the Company be obligated
to issue fractional Warrant Shares or fractional portions of any securities upon the exercise of the Warrant.

 

(g)
Duration of Adjustment. Following each computation or readjustment as provided in this Section 5, the new adjusted Warrant
Price and number of Warrant Shares purchasable upon exercise of this Warrant shall remain in effect until a further computation
or readjustment thereof is required.

 

(h)
Notwithstanding any other provision, the Company shall have the right to increase the number of authorized shares and outstanding
shares without the Holder receiving any additional Warrant or Warrant Shares as a result thereof.

 

    	 	 5	 

     

    

 

6.
Notice to Holders.

 

		(a)	Notice
                                         of Record Date. In case:

 

(i)
the Company shall take a record of the holders of its Common Stock (or other stock or securities at the time receivable upon the
exercise of this Warrant) for the purpose of entitling them to receive any dividend (other than a cash dividend payable out of
earned surplus of the Company) or other distribution, or any right to subscribe for or purchase any shares of stock of any class
or any other securities, or to receive any other right;

 

(ii)
of any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation with
or merger of the Company into another corporation, or any conveyance of all or substantially all of the assets of the Company
to another corporation; or

 

(iii)
of any voluntary dissolution, liquidation or winding-up of the Company;

 

then,
and in each such case, the Company will mail or cause to be mailed to the Holder hereof at the time outstanding a notice specifying,
as the case may be, (i) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and
stating the amount and character of such dividend, distribution or right, or (ii) the date on which such reorganization, reclassification,
consolidation, merger, conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any, is to be fixed,
as of which the holders of record of Common Stock (or such stock or securities at the time receivable upon the exercise of this
Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock or securities) for securities or other
property deliverable upon such reorganization, reclassification, consolidation, merger, conveyance, dissolution or winding-up.
Such notice shall be mailed at least ten (10) calendar days prior to the record date therein specified, or if no record date shall
have been specified therein, at least ten (10) days prior to such specified date.

 

(b)
Certificate of Adjustment. Whenever any adjustment shall be made pursuant to Section 5 hereof, the Company shall promptly
make a certificate signed by its Chairman, Chief Executive Officer, President, Vice President, Chief Financial Officer or Treasurer,
setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method by which such
adjustment was calculated and the Warrant Price and number of Warrant Shares purchasable upon exercise of this Warrant after giving
effect to such adjustment, and shall promptly cause copies of such certificates to be mailed (by first class mail, postage prepaid)
to the Holder of this Warrant.

 

7. Loss,
Theft, Destruction or Mutilation. Upon receipt by the Company of evidence satisfactory to it, in the exercise of its reasonable
discretion, of the ownership and the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or
destruction, of indemnity reasonably satisfactory to the Company and, in the case of mutilation, upon surrender and cancellation
thereof, the Company will execute and deliver in lieu thereof, without expense to the Holder, a new Warrant of like tenor dated
the date hereof.

 

8. Warrant
Holder Not a Stockholder. The Holder of this Warrant, as such, shall not be entitled by reason of this Warrant to any
rights whatsoever as a stockholder of the Company, including but not limited to voting rights. No provision hereof, in the absence
of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights
or privileges of Holder, shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder
of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

9. Registration
Rights. The Warrant Shares are entitled to the registration rights pursuant to the registration rights agreement, dated
November [  ], 2017, by and among the Company and the purchaser signatories thereto.

 

    	 	 6	 

     

    

 

10. Notices.
Any notice provided for in this Warrant must be in writing and must be either personally delivered, mailed by first class
mail (postage prepaid and return receipt requested), or sent by reputable overnight courier service (charges prepaid) to the recipient
at the address below indicated:

 

If
to the Company:

 

Intellinetics,
Inc.

2190
Dividend Drive,

Columbus,
OH 43228

Attention:
James F. DeSocio

President
and Chief Executive Officer

 

If
to the Holder:

 

To
the address of such Holder set forth on the books and records of the Company.

 

or
such other address or to the attention of such other person as the recipient party shall have specified by prior written notice
to the sending party. Any notice under this Warrant will be deemed to have been given (a) if personally delivered, upon such delivery,
(b) if mailed, five days after deposit in the U.S. mail, or (c) if sent by reputable overnight courier service, one business day
after such services acknowledges receipt of the notice.

 

11. Choice
of Law. THIS WARRANT IS ISSUED UNDER AND SHALL FOR ALL PURPOSES BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS
OF THE STATE OF OHIO, WITHOUT GIVING EFFECT TO ITS CONFLICTS OF LAW RULES.

 

12. Submission
to Jurisdiction. EACH OF THE HOLDER AND THE COMPANY SUBMITS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT SITTING
IN THE COUNTY OF FRANKLIN, STATE OF OHIO, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT AND AGREES THAT
ALL CLAIMS IN RESPECT OF THE ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT. EACH OF THE HOLDER AND THE COMPANY
ALSO AGREE NOT TO BRING ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT IN ANY OTHER COURT. EACH OF THE PARTIES
WAIVES ANY DEFENSE OF INCONVENIENT FORUM TO THE MAINTENANCE OF ANY ACTION OR PROCEEDING SO BROUGHT AND WAIVES ANY BOND, SURETY,
OR OTHER SECURITY THAT MIGHT BE REQUIRED OF ANY OTHER PARTY WITH RESPECT THERETO.

 

13. Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem
and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

14.
Miscellaneous.

 

(a)
Remedies. Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and
not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(b)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares.

 

 

(c)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

(d)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

[signature
page follows]

 

    	 	 7	 

     

    

 

IN
WITNESS WHEREOF, the Company has duly caused this Warrant to be signed on its behalf, in its corporate name and by a duly authorized
officer, as of this [_____ day of _______________, 2017].

 

	 	INETLLINETICS,
    INC.
	 	 
	 	By:	/s/ James
    F. DeSocio
	 	 	James
    F. DeSocio
	 	 	President
    and Chief Executive Officer

 

    	 	 8	 

     

    

 

EXHIBIT
A

SUBSCRIPTION
FORM

Intellinetics,
Inc.

2190
Dividend Drive,

Columbus,
OH 43228

Attention:
President and Chief Executive Officer

 

	1)	The
    undersigned hereby elects to purchase ______________ Warrant Shares of Intellinetics, Inc., a Nevada corporation, pursuant
    to the terms of the attached Warrant to Purchase Common Stock, and tenders herewith payment of the exercise price in full,
    together with all applicable transfer taxes, if any.
	 	 
	2)	Payment
    shall take the form of (check applicable box):

 

[  ]
in lawful money of the United States;

 

[  ]
the cancellation of __________ Warrant Shares in order to exercise this Warrant with respect to ____________ Warrant Shares (using
a Fair Market Value of $______ for this calculation), in accordance with the formula and procedure set forth in Section 1(c) of
the Warrant; or

 

[  ]
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula and procedure set forth in Section
1(c) of the Warrant, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to a cashless
exercise.

 

	3)	Please
    issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name
    as is specified below:

 

 

 

The
Warrant Shares shall be delivered to the following DWAC Account Number, if permitted, or by physical delivery of a certificate
to:

 

 

 

 

 

 

	4)	If
    such number of Warrant Shares shall not be all the shares receivable upon exercise of the attached Warrant, the undersigned
    requests that a new Warrant for the balance of the shares covered by the attached Warrant be registered in the name of, and
    delivered to:

 

 

 

 

 

 

 

5)
In lieu of receipt of a fractional share of Common Stock, the undersigned will receive a check representing payment therefor.

 

    	 	 A-1	 

     

    

 

	Dated:
_____________________________________    	 	 
		 	PRINT
    WARRANT HOLDER NAME
	 	 	 	 
	 	 	 	 
	 	 	Name:	                   
	 	 	Title:	 
	Witness:	 	 	 
	 	 	 	 
	 	 	 	 

 

    	 	 A-2	 

     

    

 

EXHIBIT
B

ASSIGNMENT
FORM

Intellinetics,
Inc.

2190
Dividend Drive,

Columbus,
OH 43228

Attention:
President and Chief Executive Officer

 

FOR
VALUE RECEIVED, _________________________________ hereby sells, assigns and transfers unto

 

(Please
print assignee’s name, address and Social Security/Tax Identification Number)

 

	 	 
	 	 
	 	 
	 	 
	 	 

 

the
right to purchase shares of common stock, par value $0.001 per share, of Intellinetics, Inc., a Nevada corporation (the “Company”),
represented by this Warrant to the extent of shares as to which such right is exercisable and does hereby irrevocably constitute
and appoint ____________________________, Attorney, to transfer the same on the books of the Company with full power of substitution
in the premises.

 

	Dated:
_____________________________________    	 	 
		 	PRINT
    WARRANT HOLDER NAME
	 	 	 	 
	 	 	 	 
	 	 	Name:	                   
	 	 	Title:	 
	Witness:	 	 	 
	 	 	 	 
	 	 	 	 

 

    	 	 B-1Exhibit 4.1

 

THE
SECURITIES REFERENCED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT
SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.

 

SUBORDINATED
CONVERTIBLE PROMISSORY NOTE

 

	$1,800,000	Issuance
    Date: November 21, 2017

 

For
value received, MoviePass Inc., a Delaware corporation (the “Company”), promises to pay to Helios and Matheson
Analytics Inc., a Delaware corporation (the “Holder”), the principal sum of One Million Eight Hundred Thousand
Dollars ($1,800,000), or such lesser amount as shall then equal the outstanding principal amount hereunder (the “Principal
Amount”). Interest shall accrue on this Note from the Issuance Date of this Note on the unpaid Principal Amount at a
rate equal to 5.00% per annum, compounded annually and computed on the basis of a 365-day year and the actual number of days elapsed.
This Note is being issued to the Holder pursuant to that certain Second Amended and Restated Subordinated Convertible Note Purchase
Agreement, dated August 18, 2017, as amended from time to time, among the Company, the Holder and a Requisite Majority (as defined
therein) (the “Amended Note Purchase Agreement”), that certain Securities Purchase Agreement, dated August
15, 2017, as amended on October 6, 2017, by and between the Company and the Holder (the “SPA”), subject to
that certain Waiver Agreement, dated November 6, 2017, by and between the Company and the Holder, and that certain Investment
Option Agreement, dated October 11, 2017, by and between the Company and the Holder (the “Option Agreement”).
Capitalized terms not otherwise defined herein have the meaning given them in the Option Agreement or the SPA, as applicable.
This Note is subject to the following terms and conditions.

 

	1)	Maturity.
                                         While this Note is outstanding, the Principal Amount and any accrued but unpaid interest
                                         under this Note shall be due and payable upon demand of the Holder at any time after
                                         the two-year anniversary of the Issuance Date of this Note first stated above (the “Maturity
                                         Date”). Subject to Section 2 below, interest shall accrue on this Note and
                                         shall be due and payable on the Maturity Date. Notwithstanding the foregoing, the entire
                                         unpaid Principal Amount, together with accrued and unpaid interest thereon, shall become
                                         immediately due and payable upon the commencement of any bankruptcy, insolvency or dissolution
                                         proceeding by the Company, the execution by the Company of a general assignment for the
                                         benefit of creditors, the filing by or against the Company of a petition in bankruptcy
                                         or any petition for relief under the federal bankruptcy act or the continuation of such
                                         petition without dismissal for a period of 90 days or more, or the appointment of a receiver
                                         or trustee to take possession of the property or assets of the Company.

 

	2)	Cancellation
                                         of Note Upon Consummation of SPA Transaction. Upon
                                         the Closing:

 

		a)	this
                                         Note shall be immediately cancelled and of no further force or effect, automatically
                                         and without any action being required on the part of the Holder, and the Company will
                                         be forever released from all of its obligations and liabilities under this Note including
                                         (without limitation) the obligation to pay the Principal Amount and accrued interest;

 

     

     

    

 

		b)	cancellation
                                         of this Note as provided above shall constitute full satisfaction of the Holder’s
                                         obligation to pay the purchase price for $1,800,000 of the Option Shares pursuant to
                                         the Option Agreement; and

 

		c)	the
                                         Holder shall deliver any original executed copy of this Note in the Holder’s possession
                                         to the Company for destruction, provided that any failure by the Holder to deliver such
                                         original executed copy of this Note to the Company shall not affect the automatic cancellation
                                         of this Note as provided by Section 2(a) above.

 

	3)	Next
                                         Equity Conversion.

 

		a)	Next
                                         Equity Financing. If the Holder terminates the SPA due to the Company’s
                                         material breach of any representation, warranty or covenant thereof that remains uncured
                                         within the time frame specified in Section 7.18 of the SPA (an “SPA Termination”),
                                         the outstanding Principal Amount and any accrued but unpaid interest under this Note
                                         (the amount being converted, the “Conversion Amount”) may, at the
                                         Holder’s option, be converted, in whole or in part, into equity securities issued
                                         and sold at the initial closing of the Company’s next equity financing following
                                         such SPA Termination (the “Next Equity Securities”) in a single transaction
                                         or a series of related transactions yielding gross proceeds to the Company of at least
                                         $1,000,000 (excluding the principle amount or accrued interest or any other amounts owing
                                         on any notes, including the Notes (as defined in the Amended Note Purchase Agreement),
                                         converted into capital stock and issued therein) other than an Exempt Issuance (the “Next
                                         Equity Financing”). “Exempt Issuance” means the issuance
                                         of (a) shares of the Company’s common stock, options or other equity-based awards
                                         to employees, officers, directors, consultants or vendors of the Company for services
                                         rendered to the Company pursuant to any stock or option plan or agreement that was duly
                                         adopted for such purpose, by a majority of the non-employee members of the Board of Directors
                                         or a majority of the members of a committee of non-employee directors established for
                                         such purpose, (b) securities upon the exercise or exchange of or conversion of any Notes
                                         issued hereunder and/or other securities exercisable or exchangeable for or convertible
                                         into shares of Company’s common stock issued and outstanding on the date of this
                                         Note, provided that such securities have not been amended since the date of this Note
                                         to increase the number of such securities or to decrease the exercise price, exchange
                                         price or conversion price of such securities (other than in connection with stock splits
                                         or combinations) or to extend the term of such securities and (c) securities issued pursuant
                                         to acquisitions or strategic transactions of other assets or businesses approved by a
                                         majority of the disinterested directors of the Company or the shareholders of the Company
                                         prior to such issuance; provided that (x) the primary purpose of such issuance is not
                                         to raise capital, (y) the purchaser or acquirer of such shares of the Company’s
                                         common stock in such issuance solely consists of either (1) the actual owners of such
                                         assets or securities acquired in such merger or acquisition or (2) the shareholders,
                                         partners or members of the foregoing persons, and (z) the number or amount (as the case
                                         may be) of such shares of the Company’s common stock issued to such person by the
                                         Company shall not be disproportionate to such person’s actual ownership of such
                                         assets or securities to be acquired by the Company (as applicable).

 

		b)	Notice
                                         of Conversion. If this Note is eligible to be converted pursuant to Section 3(a),
                                         at least fifteen (15) business days prior to the proposed initial closing of the Next
                                         Equity Financing, the Company shall deliver written notice to the Holder of this Note
                                         at the address last shown on the records of the Company for the Holder or given by the
                                         Holder to the Company for the purpose of notice or, if no such address appears or is
                                         given, at the place where the principal executive office of the Company is located, notifying
                                         the Holder of the Next Equity Financing, specifying the conversion price, the Principal
                                         Amount and accrued interest of this Note eligible to be converted, the proposed closing
                                         date of the proposed Next Equity Financing requesting the Holder notify the Company of
                                         its election to convert this Note if any, in the manner and at the place designated in
                                         the Company’s notice. A Holder’s election to convert all or a portion of
                                         this Note in connection with the Next Equity Financing must be made at least five (5)
                                         business days before the expected initial closing date of the Next Equity Financing.

 

    	 	2	 

     

    

 

		c)	Terms
                                         of Conversion. The number of shares of Next Equity Securities to be issued upon
                                         such conversion shall be equal to the quotient obtained by dividing (i) the Conversion
                                         Amount by (ii) 80.00% of the cash price per share of the Next Equity Securities sold
                                         in the Next Equity Financing (excluding the Participation Shares, as defined in the Amended
                                         Note Purchase Agreement), rounded down to the nearest whole share (the “Note
                                         Conversion Price”). The issuance of such shares upon such conversion shall
                                         be upon the terms and subject to the conditions applicable to the Next Equity Financing
                                         and the Company’s Certificate of Incorporation, Bylaws, and other corporate governing
                                         documents, as determined by the Company and the investors in the Next Equity Financing
                                         in their sole discretion. The Note Conversion Price, however, shall not be greater than
                                         the quotient obtained by dividing (x) $210,000,000 by (y) the total number of shares
                                         of Common Stock outstanding (assuming full conversion and exercise of all convertible
                                         or exercisable securities other than (i) the Notes (as defined in the Amended Note Purchase
                                         Agreement), (ii) other outstanding convertible notes and (iii) outstanding convertible
                                         equity securities). Upon such conversion of this Note, the Holder hereby agrees to execute
                                         and deliver to the Company all transaction documents related to the Next Equity Financing,
                                         including any purchase agreement and other ancillary agreements, with customary representations
                                         and warranties and transfer restrictions (including, without limitation, a lock-up agreement
                                         in connection with an initial public offering).

 

	4)	Change
                                         of Control. In the event of a Change of Control (as defined below) prior to the
                                         conversion of this Note or repayment in full of this Note, immediately prior to such
                                         Change of Control, this Note shall become immediately due and payable. The term “Change
                                         of Control” means (i) a sale of all or substantially all of the Company’s
                                         assets other than to an Excluded Entity (as defined below), (ii) a merger, consolidation
                                         or other capital reorganization or business combination transaction of the Company with
                                         or into another corporation, limited liability company or other entity other than an
                                         Excluded Entity, or (iii) the consummation of a transaction, or series of related transactions,
                                         in which any “person” (as such term is used in Sections 13(d) and 14(d) of
                                         the Securities Exchange Act of 1934, as amended (the “Exchange Act”))
                                         becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange
                                         Act), directly or indirectly, of all of the Company’s then outstanding voting securities.
                                         Notwithstanding the foregoing, a transaction shall not constitute a Change of Control
                                         if its purpose is to (A) change the jurisdiction of the Company’s incorporation,
                                         (B) create a holding company that will be owned in substantially the same proportions
                                         by the persons who hold the Company’s securities immediately before such transaction,
                                         or (C) obtain funding for the Company in a financing that is approved by the Company’s
                                         Board of Directors. An “Excluded Entity” means a corporation or other
                                         entity of which the holders of voting capital stock of the Company outstanding immediately
                                         prior to such transaction are the direct or indirect holders of voting securities representing
                                         at least a majority of the votes entitled to be cast by all of such corporation’s
                                         or other entity’s voting securities outstanding immediately after such transaction.

 

    	 	3	 

     

    

 

	5)	Mechanics
                                         and Effect of Conversion. No fractional shares of the Company’s capital
                                         stock will be issued upon conversion of this Note. In lieu of any fractional share to
                                         which the Holder would otherwise be entitled, the Company will pay to the Holder in cash
                                         the amount of the unconverted Principal Amount and accrued interest under this Note that
                                         would otherwise be converted into such fractional share. Upon conversion of this Note,
                                         the Holder shall surrender this Note, duly endorsed, at the principal offices of the
                                         Company or any transfer agent of the Company. At its expense, the Company will, as soon
                                         as practicable thereafter, issue the number of Next Equity Securities to which such Holder
                                         is entitled upon such conversion, together with any other securities and property to
                                         which the Holder is entitled upon such conversion under the terms of this Note, including
                                         a check payable to the Holder for any cash amounts payable as described herein and shall
                                         deliver to such Holder, at such principal office, a notice of issuance upon request for
                                         the number of shares to which such Holder is entitled upon such conversion. Upon conversion
                                         of this Note, the Company will be forever released from all of its obligations and liabilities
                                         under this Note with regard to that portion of the principal amount and accrued interest
                                         being converted including (without limitation) the obligation to pay such portion of
                                         the principal amount and accrued interest.

 

	6)	Payment;
                                         Prepayment. All payments shall be made in lawful money of the United States of
                                         America at such place as the Holder hereof may from time to time designate in writing
                                         to the Company. Payment shall be credited first to collection costs, if any, then the
                                         accrued interest then due and payable and the remainder shall be applied to principal.
                                         The Company may prepay this Note at any time without penalty only upon written consent
                                         of the Holder.

 

	7)	Stockholders,
                                         Officers and Directors Not Liable. In no event shall any stockholder, officer
                                         or director of the Company be liable for any amounts due or payable pursuant to this
                                         Note.

 

	8)	Subordination.

 

		a)	The
                                         indebtedness evidenced by this Note is hereby expressly subordinated, to the extent and
                                         in the manner hereinafter set forth, in right of payment to the prior payment in full
                                         of all of the Company’s Senior Indebtedness. The Holder further agrees to execute
                                         a form of subordination agreement, as requested by any current or future lender to the
                                         Company, to effect the foregoing subordination. “Senior Indebtedness”
                                         shall mean the principal of and unpaid interest and premium, if any, on (i) indebtedness
                                         of the Company or with respect to which the Company is a guarantor, whether outstanding
                                         on the date hereof or hereafter created, to banks, insurance companies or other lending
                                         or thrift institutions regularly engaged in the business of lending money, whether or
                                         not secured, (ii) any deferrals, renewals or extensions or any debentures, notes or other
                                         evidence of indebtedness issued in exchange for such Senior Indebtedness, (iii) those
                                         certain secured convertible promissory notes issued by the Company pursuant to the Secured
                                         Convertible Promissory Note and Warrant Purchase Agreement dated on May 27, 2016.

 

		b)	Upon
                                         any receivership, assignment for the benefit of creditors, bankruptcy, reorganization,
                                         or arrangement which creditors (whether or not pursuant to bankruptcy or other insolvency
                                         laws), sale of all or substantially all of the assets, dissolution, liquidation, or any
                                         other marshaling of the assets and liabilities of the Company or in the event this Note
                                         shall be declared due and payable, (i) no amount shall be paid by the Company, whether
                                         in cash or property in respect of the principal of or interest on this Note at the time
                                         outstanding, unless and until the full amount of any Senior Indebtedness then outstanding
                                         shall be paid in full, and (ii) no claim or proof of claim shall be filed with the Company
                                         by or on behalf of the holder of this Note which shall assert any right to receive any
                                         payments in respect of the principal of and interest on this Note except subject to the
                                         payment in full all of the Senior Indebtedness then outstanding.

 

		c)	If
                                         an event of default has occurred with respect to any Senior Indebtedness, permitting
                                         the holder thereof to accelerate the maturity thereof, then unless and until such event
                                         of default shall have been cured or waived or shall have ceased to exist, or all Senior
                                         Indebtedness shall have been paid in full, no payment shall be made in respect of the
                                         principal of or interest on this Note.

 

    	 	4	 

     

    

 

		d)	Nothing
                                         contained in the preceding paragraphs shall impair, as between the Company and the Holder,
                                         the obligation of the Company, which is absolute and unconditional, to pay to the Holder
                                         hereof the principal hereof and interest hereon as and when the same shall become due
                                         and payable, or shall prevent the Holder, upon default hereunder, from exercising all
                                         rights, powers and remedies otherwise provided herein or by applicable law, all subject
                                         to the rights, if any, of the holders of Senior Indebtedness under the preceding paragraphs
                                         to receive cash or other properties otherwise payable or deliverable to the Holder pursuant
                                         to this Note.

 

	9)	Interest
                                         Rate Limitation. Notwithstanding anything to the contrary contained in this Note,
                                         the Amended Note Purchase Agreement, the SPA or the Option Agreement, as applicable (the
                                         “Loan Documents”), the interest paid or agreed to be paid under the
                                         Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by
                                         applicable law (the “Maximum Rate”). If the Holder shall receive interest
                                         in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the
                                         principal remaining owed under this Note or, if it exceeds such unpaid principal, refunded
                                         to the Company. In determining whether the interest contracted for, charged, or received
                                         by the Holder exceeds the Maximum Rate, the Holder may, to the extent permitted by applicable
                                         law, (a) characterize any payment that is not principal as an expense, fee, or premium
                                         rather than interest, (b) exclude voluntary prepayments and the effects thereof, and
                                         (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount
                                         of interest throughout the contemplated term of this Note.

 

	10)	Action
                                         to Collect on Note. If action is instituted to collect on this Note, the Company
                                         promises to pay all of each Holder’s costs and expenses, including reasonable attorney’s
                                         fees, incurred in connection with such action.

 

	11)	Loss
                                         of Note. Upon receipt by the Company of evidence satisfactory to it of the loss,
                                         theft, destruction or mutilation of this Note or any Note exchanged for it, and indemnity
                                         satisfactory to the Company (in case of loss, theft or destruction) or surrender and
                                         cancellation of such Note (in the case of mutilation), the Company will make and deliver
                                         in lieu of such Note a new Note of like tenor.

 

	12)	Miscellaneous.

 

		a)	Governing
                                         Law; Venue. The validity, interpretation, construction and performance of this
                                         Note, and all acts and transactions pursuant hereto and the rights and obligations of
                                         the Company and Holder shall be governed, construed and interpreted in accordance with
                                         the laws of the State of California, without giving effect to principles of conflicts
                                         of law. Venue for any legal action under this Note shall be in the state or federal courts
                                         located in the City of Los Angeles in the State of California.

 

		b)	Entire
                                         Agreement. This Note, together with the Amended Note Purchase Agreement, the
                                         SPA, the Option Agreement and the documents referred to therein, constitute the entire
                                         agreement and understanding between the Company and the Holder relating to the subject
                                         matter herein and supersede all prior or contemporaneous discussions, understandings
                                         and agreements, whether oral or written between them relating to the subject matter hereof.

 

		c)	Amendments
                                         and Waivers. Any term of this Note may be amended only with the written consent
                                         of the Company and the Holder. Any amendment or waiver effected in accordance with this
                                         Section 12(c) shall be binding upon the Company, the Holder and each transferee of the
                                         Note or any portion thereof.

 

		d)	Successors
                                         and Assigns. The terms and conditions of this Note shall inure to the benefit
                                         of and be binding upon the respective successors and assigns of the Company and the Holder.
                                         Notwithstanding the foregoing, the Holder may not assign, pledge, or otherwise transfer
                                         this Note without the prior written consent of the Company except pursuant to the exercise
                                         of rights by the holder(s) of Helios’ senior secured convertible notes holding
                                         a security interest in Helios’ assets. Subject to the preceding sentence, this
                                         Note may be transferred only upon surrender of the original Note for registration of
                                         transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer
                                         in form satisfactory to the Company. Thereupon, a new note for the same principal amount
                                         and interest will be issued to, and registered in the name of, the transferee. Interest
                                         and principal are payable only to the registered holder of this Note.

 

		e)	Notices.
                                         Any notice, demand or request required or permitted to be given under this Note shall
                                         be in writing and shall be deemed sufficient when delivered personally or by overnight
                                         courier or sent by email, or 48 hours after being deposited in the U.S. mail as certified
                                         or registered mail with postage prepaid, addressed to the party to be notified at such
                                         party’s address as set forth on the signature page, as subsequently modified by
                                         written notice, or if no address is specified on the signature page, at the most recent
                                         address set forth in the Company’s books and records.

 

		f)	Counterparts.
                                         This Note may be executed in any number of counterparts, each of which when so executed
                                         and delivered shall be deemed an original, and all of which together shall constitute
                                         one and the same instrument.

 

[Signature
Page Follows]

 

    	 	5	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Subordinated Convertible Promissory Note as of the date first set forth above.

 

	 	THE
    COMPANY:
	 	 	 
	 	MOVIEPASS INC.
	 	 	 
	 	By:
    	/s/
    J Mitchell Lowe
	 	 	(Signature)
	 	Name:
    	J
    Mitchell Lowe
	 	Title:
    	CEO
	 	 	 
	 	Address:  	175 Varick,
NY, NY 10014

 

	AGREED TO AND ACCEPTED:	 
	 	 
	THE
    HOLDER:	 
	 	 
	HELIOS AND MATHESON ANALYTICS INC.	 
	 	 
	By:	/s/
    Stuart Benson	 
	 	(Signature)	 
	Name:	Stuart
Benson	 
	Title:	CFO	 
	 	 	 
	Address: 	350
    Fifth Avenue Suite #7520	 
	 	New York, NY
10118	 

 

[Signature
Page to the Subordinated Convertible Promissory Note of MoviePass Inc.]

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]